TrialBlood advances2021

Tisagenlecleucel immunogenicity in relapsed/refractory acute lymphoblastic leukemia and diffuse large B-cell lymphoma.

Karen Thudium Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.